Navigation Links
Men Estimate Men's Risks Of Common Disorders Higher Than Women Do, And Vice Versa

New research from University of Glasgow researchers on lay perceptions about gender differences in health reveals that both men and women believe health risks are higher for their own sex than for the opposite sex. But, it also shows that males think that men are fitter and females think women are more athletic.

Professor Sally Macintyre in the MRC Social and Public Health Sciences Unit at the University of Glasgow analysed responses from 466 women and 353 men, aged 25, 45, and 65, to a questionnaire that asked whether they thought men or women (or both equally) were more likely to have heart disease, cancer, mental illness and accidents, to be fit and to live longer.

The research provides insights about gender identity and difference. They found that each gender tends to think risks are higher for their own sex than for the other gender. Previous studies suggest that lay people and health professionals operate on stereotypes about the gender patterning of certain types of health problem and health behaviour. For example, coronary heart disease tends to be perceived as a 'male disease' even though it is the leading cause of mortality amongst women in the UK. (One study found that 30 year old women with chest pain were much less likely than 30 year old men to be given a cardiac diagnosis, much more likely to be given a psychiatric diagnosis, and around seven times more likely to be considered not to need medical treatment).

The University of Glasgow study reveals that when a respondent considered one sex more at risk than the other, men were thought more likely to have accidents and women to have cancer and mental illness. Accidents: 48 per cent of males compared to 37 per cent of females said men were more likely to have accidents; 58 per cent of females chose 'both', compared to 50 per cent of males.

Cancer: around two thirds of both sexes said they believed men and women were 'equally likely' to experience cancer; 12 per cent of male
'"/>

Source:University of Glasgow


Page: 1 2

Related biology news :

1. New Estimates For The Causes Of Child Deaths Worldwide
2. South African Tribunal Asks For Damages Estimates in GSK AIDS Drug Case
3. Youth With HIV Take More Risks After New Meds Introduced
4. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
5. Harmful Bacterium Commonly Found in Poultry May Survive Refrigeration and Frozen Storage Combined
6. Use of Antibiotics for Acne May Increase Risk of Common Illness
7. Common viruses may cause cancer
8. Common alternative treatment for liver disease is found to be ineffective
9. Common molecular signature identified in solid tumors
10. Common bacteria pirate natural mechanism to get inside cells
11. Commonly used antidepressants may also affect human immune system
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Men Estimate Men Risks Common Disorders Higher Than Women And Vice Versa

(Date:7/23/2015)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its second quarter ended June 30, 2015.  ... a decrease of 33% compared to $6.8 million in the ... of 2015 was $0.3 million, or $0.01 per diluted share, ... in the same period a year ago.  ...
(Date:7/20/2015)...  Acuity Market Intelligence,s latest research "The Global ... and Privacy" forecasts that between 2014 and 2020 ... downloaded to smart mobile devices by 2.2 billion ... projected to generate more than $67.9 billion in ... period.    "Biometrics is at the ...
(Date:7/9/2015)... PLEASANTON, Calif. , July 9, 2015 /PRNewswire/ ... tools, today announcing its acquisition of Avid Nano. ... dynamic light scattering (DLS) systems.    ... world,s smallest, fastest and easiest to use protein ... system that measures a protein,s hydrodynamic size, size ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... Cold Spring Harbor, NY A team of researchers at ... of DNA called an enhancer element that enables cancerous blood ... cancer that is incurable in 70% of patients. Just ... a new class of promising drugs one version of ...
... Calif. John Trumble , a distinguished professor ... Riverside, has been named the recipient of the 2013 ... and/or extension education benefiting the California vegetable industry. ... problems in agricultural and natural ecosystems, will receive the ...
... in the form of humidity, water spills, or rainfall ... displays, TVs, and solar photovoltaic (PV) panels worldwide. Standing ... a transparent film barrier that must work flawlessly year after ... test that can detect infinitesimally small amounts of moisture ...
Cached Biology News:Scientists discover how leukemia cells exploit 'enhancer' DNA elements to cause lethal disease 2Scientists discover how leukemia cells exploit 'enhancer' DNA elements to cause lethal disease 3Entomologist recognized for exceptional service to California's vegetable industry 2NREL test helps make moisture barriers better 2NREL test helps make moisture barriers better 3NREL test helps make moisture barriers better 4NREL test helps make moisture barriers better 5NREL test helps make moisture barriers better 6NREL test helps make moisture barriers better 7
(Date:7/29/2015)... NJ (PRWEB) , ... July 29, 2015 , ... The ... approval of combination products , in particular, drug/device combinations. The current system received ... by the Initiative for Patient Centered Innovation (iPCI) of Fairleigh Dickinson University’s ...
(Date:7/29/2015)... ... 29, 2015 , ... Available in select spas and ... nighttime-specific product that targets fat cells for extreme contouring action. During sleep key ... cells, inhibiting the formation of new fat. Upon waking CHRONODIET breaks down fat ...
(Date:7/28/2015)... -- A n ew ... developing and commercialising innovative medicines to transform patient quality of ... experienced management team; blue chip ... BioPharma Group Ltd ("Mereo"), a recently-formed speciality biopharmaceutical company, announces ... gross, from blue chip institutional investors and simultaneously acquired a ...
(Date:7/28/2015)... Mass. , July 28, 2015 ... measuring cell metabolism, is the provider of XF ... across all disease research areas. As the links ... exploration into cell metabolism is escalating rapidly.   ... published by the Nature Publishing Group (NPG) featuring ...
Breaking Biology Technology:Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 2Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 2XF Technology Used to Demonstrate Feasibility of Stem Cell Regenerative Technique 3
... Imaging and Printing Group and its Personal Systems Group into ... milestone in HPs journey to become the consumer ... a unified and convincing product message for every room in ... HPs consumer message into overdrive. , ,The consumer technology market ...
... Merge Technologies Incorporated and Cedara Software Corp. ... develop health-care software, particularly digital medical imaging. , ,Pending stockholder ... in Milwaukee. Merge CEO Richard Linden will stay ... Abe Schwartz will stay on the board of directors. Merge ...
... an idea of what Madison could offer to the field ... how many new visitors our coverage of last Thursday's ... WTN 's Web site. Our normal recurring readership is ... than half are from out-of-state and about 15 percent read ...
Cached Biology Technology:HP charges toward the living room 2HP charges toward the living room 3International eyes drawn to Madison's games research 2International eyes drawn to Madison's games research 3International eyes drawn to Madison's games research 4
... , Coated Capture Antibody: 12 x 8-well strips, ... mL of 2X concentrate , Beta Amyloid ... , Lyophilized Standard Diluent: 3 mL , Primary ... Antibody-HRP: 30 microL of concentrate , OPD Substrate: ...
Human Cell Line Slides...
Request Info...
HSV 1 IgM...
Biology Products: